Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Acute leukaemia, Acute myeloid leukaemia (AML), Blood cancers, Leukaemia
Closed
Phase 3
This trial is comparing venetoclax and azacitidine with azacitidine for acute myeloid leukaemia (AML). In this trial, the team are looking at having azacitidine as a tablet.
It is for people who have had chemotherapy and their leukaemia went away completely. This is called remission. It means there are no leukaemia cells in your blood or .
Recruitment start: 6 October 2020
Recruitment end: 10 March 2023
Please note: In order to you will need to discuss it with your doctor, unless otherwise specified.
Dr Richard Dillon
AbbVie
Last reviewed: 01 Dec 2023
CRUK internal database number: 16801
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Connect with other people affected by cancer and share your experiences.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
